What Analysts Recommend for Hologic ahead of Third-Quarter Results
Hologic (HOLX), a leading women’s health technology player, will release its fiscal third-quarter earnings results on July 31 after markets close. The stock fell more than 9% following the results. Many analysts covering Hologic cut their target prices on HOLX stock in the following days. As of July 30, Reuters reported that of the 19 analysts covering Hologic, ~63% have a “buy” or “strong buy” rating on HOLX stock.